Search Results for 'Formulation Development'
Contract Service Directory Companies
Microsite Companies
Featured Companies
View All Buyers Guide Companies »
Contract Service Directory Categories
View All Categories »
-
Analytical Services | APIs | cGMP Manufacture | Excipients | Formulation Development | QA/QC | R&D | Solid Dosage/Semi-solids
Enteris BioPharma: Custom Solutions – From Bench to Market
CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.
-
Clinical Trial Materials | Drug Development | Formulation Development
On-Demand Webinar: Accelerated Timelines for Clinical Supply Manufacture
Watch this on-demand webinar to gain a deeper understanding of the value of adaptive processes at this critical early stage of drug development.
-
Breaking News | cGMP Manufacture | Formulation Development | Industry News
Piramal Pharma Solutions, Plus Therapeutics Ink MSA
Piramal to perform services related to the development, manufacture, and supply of Plus Therapeutics’ RNL-Liposome Intermediate Drug Product.Kristin Brooks 03.24.21
-
Breaking News | Formulation Development | Industry News
Cybin to Leverage Catalent’s Zydis for Psychiatric Drug
To apply Zydis orally disintegrating tablet (ODT) technology for delivery of Cybin’s potential therapy for treatment-resistant psychiatric disorders.Kristin Brooks 03.22.21
-
Breaking News | Formulation Development | Industry News
Rentschler, Leukocare Extend Service Offering with U.S. Site
Opens Leukocare’s U.S. development labs and offices at Rentschler's facility in the Greater Boston area, where the two companies will work together.Kristin Brooks 03.22.21
-
Drug Delivery | Formulation Development
On Demand Webinar - Formulation Strategies for Poorly Soluble Molecules
Pharmaceutics and Biopharmaceutics Considerations - Now Available to Watch On Demand
-
APIs | Formulation Development
Why Increasing Solubility May Not Improve Bioavailability - In Vitro Predictions
Travis Webb, Formulation Scientist at CoreRx, will discuss the use of in vitro flux and permeability as a tool in formulation dev in this March 30 webinar.02.24.21
-
APIs | Breaking News | Formulation Development | Industry News
Tris Pharma, Athena Bioscience Enter Exclusive License Agreement
Athena gains exclusive rights to commercialize a long-acting antihypertensive product developed using Tris' proprietary technology.Kristin Brooks 02.22.21
-
Breaking News | Formulation Development | Industry News | Promotions & Moves
Novartis Vet Joins CDMO Sai Life Sciences
Mahavir Prashad named as vice president of early phase process development.Tim Wright, Editor, Contract Pharma 02.17.21
-
APIs | Breaking News | Drug Development | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
Lonza Expands Solid Small Molecule Services
To encompass all aspects of solid form screening and characterization of small molecule APIs.Kristin Brooks 02.16.21
-
Breaking News | Formulation Development | Industry News | Methods Development
Adare Pharma Solutions Opens New Small-Scale Lab
Vandalia, OH lab offers customizable, flexible systems designed to expedite formulation and process development services.Kristin Brooks 01.26.21
-
Formulation Development
Coating Place Wurster Fluid Bed Process Scaling
With a 45-year history of involvement in formulation dev and application, this design strategy lends significant ease and predictability to process scale-up.
-
Breaking News | Formulation Development | Industry News
Hovione Launches ASD-HIPROS
Advanced tool designed to identify optimal and commercially viable Amorphous Solid Dispersions formulation by Spray Drying.Contract Pharma Staff 01.12.21
-
Formulation Development
Innovate | Integrate | Customize | Accelerate
-
Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
Moderna, Recipharm Enter COVID-19 Vax Mfg. Agreement
Recipharm to provide aseptic drug product manufacturing and fill-finish of Moderna’s COVID-19 vaccine outside of the U.S.Contract Pharma Staff 01.04.21
-
Formulation Development
Formulation of Monodisperse Controlled-Release Quetiapine Microspheres
Adare’s Optimμm® technology offers a unique and efficient method of fabricating monodisperse microparticles at reduced development time.
-
Breaking News | Drug Development | Formulation Development | Industry News
Vectura, Kinaset Partner to Develop Asthma Treatment
Licenses VR588 to Kinaset, Vectura will provide formulation development services to support Phase I studies and ultimately commercialization.Contract Pharma Staff 11.30.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Formulation Development | Industry News
Lonza Expands Development, Mfg. Capabilities at Bend Site
Investment will add 11 new suites for particle engineering and drug product capacity to improve program lead times.Contract Pharma Staff 11.30.20
-
Formulation Development
**ADVERTORIAL** Advanced Formulation Development by Design in the Context of Holistic Drug Production
A strong trend in drug substance and drug product biomanufacturing, as is for formulation, is that of increasing therapeutic complexity.Latika Bhonsle-Deeng, Rentschler Biopharma SE, and Konstantin Petropoulos, LEUKOCARE AG 10.14.20
-
Analytical Services | Breaking News | Formulation Development | Industry News | Laboratory Testing
Cambrex Completes Edinburgh Expansion
Doubles the facility's footprint to 15,000 sq.-ft., existing lab space is refurbished, and an additional 3,500 sq.-ft. of lab space added.Contract Pharma Staff 10.12.20
-
Breaking News | cGMP Manufacture | Formulation Development | Industry News | Scale-up/Technology Transfer
Catalent Launches OneXpress Solution
Aims to accelerate a program’s transition from early-phase development to commercial-ready manufacturing for oral dosage products.Contract Pharma Staff 10.01.20
-
Breaking News | cGMP Manufacture | Formulation Development | Industry News | Process Development
Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals
Includes Adare’s CDMO, pharmaceutical technology and microbiome businesses; will rebrand as Adare Pharma Solutions.Contract Pharma Staff 09.30.20
-
APIs | Formulation Development
Premature Release from Wurster Fluid Bed Enteric Coatings
The Wurster (bottom spray) fluid bed coating process provides an optimal means to apply enteric coatings on API or API containing particles.
-
APIs | Formulation Development
Expanding Solutions for Challenging APIs Through Coacervation
Download Adare Pharma Solutions' whitepaper to learn how the coacervation method can help solve your formulation challenges.
-
APIs | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Excipients | Formulation Development | Industry News
Piramal to Deliver Integrated Services to Epirium
Includes formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product.Contract Pharma Staff 08.27.20
-
Breaking News | Collaborations & Alliances | Formulation Development
TFF Pharmaceuticals Signs Worldwide Licensing Agreement with Union Therapeutics
Will develop dry powder forms of niclosamide as a potential COVID-19 treatment.Contract Pharma Staff 08.17.20
-
Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
Dalton, VIDO-InterVac Partner to Develop COVID-19 Vax
Dalton to provide formulation and fill/finish of VIDO-InterVac’s COVID-19 vaccine to be used in early phase clinical trials.Contract Pharma Staff 07.28.20
-
Breaking News | Drug Development | Formulation Development | Industry News | Laboratory Testing | Methods Development
MilliporeSigma Opens M Lab Collaboration Center in Shanghai
Offers customizable solutions to help advance drug development, including pilot scale and process development support labs that offer non-GMP lab space.Contract Pharma Staff 07.10.20
-
Breaking News | Collaborations & Alliances | Formulation Development
Vectura Earns $5M Novartis Milestone for Enerzair Breezhaler
Enerzair Breezhaler uses Vectura’s formulation IP, and is a first-in-class fixed-dose combination maintenance treatment for uncontrolled asthma.Contract Pharma Staff 07.07.20
-
Formulation Development | Industry News
SeraNovo, Carna Biosciences Enter Second License Agreement
To develop an oral formulation of a new active ingredient with enhanced bioavailability.Contract Pharma Staff 05.26.20
-
Formulation Development | Industry News | Trials & Filings
Triphase, Catalent Announce Interim TRPH-222 Results in NHL
TRPH-222 leverages Catalent’s SMARTag platform to provide optimized site-specific protein-modification and linker technologies.Contract Pharma Staff 05.19.20
-
Breaking News | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
Catalent, Ennaid Therapeutics Ink COVID-19 Program Pact
Catalent will develop a powder-in-capsule formulation of Ennaid’s ENU200 program, a repurposed antiviral drug for the potential treatment of COVID-19Contract Pharma Staff 05.13.20
-
Breaking News | Formulation Development | Industry News
Adare Pharma Acquires Orbis Biosciences
Expands Adare’s technology platforms and product development capabilities.Contract Pharma Staff 05.05.20
-
Breaking News | Industry News
MedPharm Helps Fight COVID-19 Outbreak
Donates hand sanitizer for healthcare providers and other essential workersContract Pharma Staff 04.15.20
-
Breaking News | Formulation Development | Industry News
Biohaven Wins FDA Approval for NURTEC ODT
Developed in partnership with Catalent using its Zydis orally disintegrating tablet (ODT) technology03.17.20
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
XtalPi Collaborates with Porton
Combining AI algorithms with targeted experiments to solve bottleneck challenges in drug developmentContract Pharma Staff 03.12.20
-
Breaking News | Collaborations & Alliances | Facilities | Industry News
Bora Pharmaceuticals to Acquire GSK Mississauga Facility
Skilled manufacturing staff to be retained as site becomes Bora's flagship North American facility03.09.20
-
Parenterals
Parenteral Drug Trends
Leading CDMOs discuss trends in the market for injectable drugs.Tim Wright, Editor, Contract Pharma 03.04.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Catalent Supports Blueprint’s AYVAKIT Approval
Nottingham UK facility to provide commercial supply of AYVAKIT02.27.20
-
WuXi Biologics, Vir Biotech Partner to Develop COVID-19 Antibodies
WuXi Biologics will conduct cell-line development, process and formulation development, and initial manufacturing for clinical development02.25.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Formulation Development | Industry News
WuXi Biologics, Vir Biotech Partner to Develop COVID-19 Antibodies
WuXi Biologics will conduct cell-line development, process and formulation development, and initial manufacturing for clinical development02.25.20
-
Analytical Services | Breaking News | CRO News | Industry News
Frontage Acquires CRO BRI
Expands geographic foothold into Canada and the West Coast of North America.01.03.20
-
Breaking News | Promotions & Moves
MedPharm Appoints North American VP
Lynn Allen brings extensive experience in topical and transdermal contract development and manufacturing12.18.19
-
Breaking News | Clinical Trial Materials | Clinical Trials | Formulation Development | Industry News
Recipharm, Aptahem Enter Formulation Development Pact
Recipharm will develop an injectable formulation of Apta-1 drug candidate for Phase I study12.17.19
-
Breaking News | Formulation Development | Industry News
Catalent, Bridge Therapeutics Execute Exclusive License Agreement
To utilize Catalent’s Zydis orally disintegrating tablet (ODT) technology for opioid addiction therapeutic product12.10.19
-
Breaking News | Drug Delivery | Industry News
MedPharm Triples Capacity at RTP Site
Invests $4M to expand topical and transdermal services in Durham, NC12.06.19
-
Breaking News | Formulation Development | Industry News
Catalent, Ethicann Partner on Fast-Dissolve Treatment
Will leverage Catalent’s Zydis ODT technology to develop a new pharmaceutical-grade CBD and THC product to treat spasticity in MS patients12.03.19
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
Piramal, BerGenBio Partner on Leukemia Drug
Piramal to leverage its Xcelerate Integrated Solutions platform and is expected to provide commercial manufacturing of the final product12.03.19
-
Breaking News | cGMP Manufacture | Industry News
Catalent, BeiGene Enter Long-Term Supply Agreement
Will manufacture BRUKINSA, a Bruton’s tyrosine kinase (BTK) inhibitor that recently received accelerated approval from the U.S. FDA.11.21.19
-
Mikart's Gus Labella
Mikart's associate director of formulation development talks about the company's services.Videos Contract Pharma Staff
